Stock Scorecard



Stock Summary for RxSight Inc (RXST) - $51.89 as of 4/25/2024 9:08:01 PM EST

Total Score

10 out of 29

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for RXST

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for RXST

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for RXST

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for RXST

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Latest News for for RXST

RxSight Announces Commercial Launch of its Newest Light Adjustable Lens™, the LAL+™, and Features Multiple Doctor Presentations at the Upcoming ASCRS Annual Meeting 4/4/2024 8:05:00 PM
RxSight Announces Commercial Launch of its Newest Light Adjustable Lens™, the LAL+™, and Features Multiple Doctor Presentations at the Upcoming ASCRS Annual Meeting - RxSight ( NASDAQ:RXST ) 4/4/2024 8:05:00 PM
RxSight, Inc. to Participate in the 23rd Annual Needham Virtual Healthcare Conference 3/27/2024 8:05:00 PM
RxSight, Inc. to Participate in the 23rd Annual Needham Virtual Healthcare Conference - RxSight ( NASDAQ:RXST ) 3/27/2024 8:05:00 PM
Is First Trust Small Cap Growth AlphaDEX ETF ( FYC ) a Strong ETF Right Now? 3/15/2024 10:20:00 AM
Should First Trust Small Cap Growth AlphaDEX ETF ( FYC ) Be on Your Investing Radar? 3/6/2024 11:20:00 AM
What's in the Offing for Brainsway ( BWAY ) in Q4 Earnings? 3/5/2024 1:20:00 PM
Is SPDR S&P Health Care Equipment ETF ( XHE ) a Strong ETF Right Now? 3/4/2024 11:20:00 AM
RxSight, Inc. to Participate in the 34th Annual Oppenheimer Healthcare Conference 3/1/2024 12:05:00 AM
RxSight, Inc. to Participate in the 34th Annual Oppenheimer Healthcare Conference - RxSight ( NASDAQ:RXST ) 3/1/2024 12:05:00 AM

Financial Details for RXST

Company Overview

Ticker RXST
Company Name RxSight Inc
Country USA
Description N/A
Sector Name LIFE SCIENCES
Industry Name OPHTHALMIC GOODS
Most Recent Quarter 12/31/2023
Next Earnings Date 5/6/2024

Stock Price History

Last Day Price 51.89
Last Day Price Updated 4/25/2024 9:08:01 PM EST
Last Day Volume 292,037
Average Daily Volume 351,376
52-Week High 58.21
52-Week Low 17.59
Last Price to 52 Week Low 195.00%

Valuation Measures

Trailing PE N/A
Industry PE 71.71
Sector PE 61.73
5-Year Average PE -9.93
Free Cash Flow Ratio 15.08
Industry Free Cash Flow Ratio 59.69
Sector Free Cash Flow Ratio 30.74
Current Ratio Most Recent Quarter 8.06
Total Cash Per Share 3.44
Book Value Per Share Most Recent Quarter 4.44
Price to Book Ratio 12.09
Industry Price to Book Ratio 3.55
Sector Price to Book Ratio 22.08
Price to Sales Ratio Twelve Trailing Months 21.73
Industry Price to Sales Ratio Twelve Trailing Months 5.62
Sector Price to Sales Ratio Twelve Trailing Months 5.16

Share Statistics

Total Shares Outstanding 36,987,600
Market Capitalization 1,919,286,564
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Dividend Aristocrat? False
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth 27.19%
Reported EPS 12 Trailing Months -1.41
Reported EPS Past Year 0.00
Reported EPS Prior Year -1.38
Net Income Twelve Trailing Months -48,608,000
Net Income Past Year -48,608,000
Net Income Prior Year -66,756,000
Quarterly Revenue Growth YOY 77.60%
5-Year Revenue Growth 110.76%

Balance Sheet

Total Cash Most Recent Quarter 127,200,000
Total Cash Past Year 127,200,000
Total Cash Prior Year 105,800,000
Net Cash Position Most Recent Quarter 127,200,000
Net Cash Position Past Year 127,200,000
Long Term Debt Past Year 0
Long Term Debt Prior Year 40,169,000
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 160,362,000
Total Stockholder Equity Prior Year 89,902,000
Total Stockholder Equity Most Recent Quarter 160,362,000

Options

Put/Call Ratio 0.00
Has Options Options Chain
Liquidity Rating None

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.82
MACD Signal 0.70
20-Day Bollinger Lower Band 35.07
20-Day Bollinger Middle Band 47.75
20-Day Bollinger Upper Band 60.43
Beta 1.22
RSI 50.62
50-Day SMA 35.18
200-Day SMA 0.00

System

Modified 4/25/2024 10:48:35 AM EST